Category: elsevier

Neuroscience journal takes tough stance on plagiarism

cortexLike Howard Beale, the character in 1976’s “Network” who famously said “I’m as mad as hell, and I’m not going to take this anymore!,” the editors of the journal Cortex have decided they’ve had enough when it comes to plagiarism.

From an editorial in the current issue:

We will treat academic plagiarism as a misdeed, not as a mistake, and a paper that plagiarizes others will be immediately rejected and may be reported to the author’s academic affiliation.

The editors explain how: Continue reading Neuroscience journal takes tough stance on plagiarism

Saudi journal retracts paper on new chemicals for being, well, not new

JSaudChemIrony alert: If you’re going to publish a paper on purportedly new molecules, please try to make sure those substances are indeed novel. Here’s case were that wasn’t quite so.

The Journal of Saudi Chemical Society has retracted a 2011 paper by a researcher who lifted the entire article from a previously published paper by someone else.

The paper in question, “Synthesis and antimicrobial activity of some new quinazolin-4(3H)-one derivatives,” came from Adnan Kadi at Kind Saud University in Riyadh. But according to the retraction notice, only a few words in that title — “some” and “quinazolin” were accurate. “New,” certainly not. (We suppose “derivatives” hits the mark, but for the wrong reason.) Continue reading Saudi journal retracts paper on new chemicals for being, well, not new

Journal withdraws diabetes paper written by apparently bogus authors

BBRCTalk about a Trojan Horse.

Biochemical and Biophysical Research Communications has withdrawn a paper it published earlier this year on metabolic proteins linked to diabetes, not because the article was bogus but because the authors appear to have been. The work itself is accurate — indeed, it likely belongs to a Harvard scientist, Bruce Spiegelman, who’d presented his data on the subject several times recently and was in the process of preparing his results for publication. We’ve written about researchers trying to punk journals with faked articles, and about a researcher who apparently made up a co-author, but here’s something new!

Nature has the story. According to Nature, in July Spiegelman: Continue reading Journal withdraws diabetes paper written by apparently bogus authors

Journal retracts two chemistry papers for plagiarism

commnonlinscinumsimCommunications in Nonlinear Science and Numerical Simulation has retracted a pair of articles by a group of chemists from Iran and the United States after finding evidence of plagiarism in the papers.

The researcher team included authors from Islamic Azad University, Ferdowski University of Mashhad and, perhaps somewhat incongruously, Ball State University in Muncie, Indiana.

The first paper, “An analytical approach to the stability of solitary solutions of cubic–quintic coupled non-linear Schrödinger equations,” appeared in 2009 and has been cited twice, according to Thomson Scientific’s Web of Knowledge. (Question: is an article that will ultimately be retracted for plagiarism considered to exist in a state of un-retracted retractionness, such that by detecting the plagiarized text the article immediately ceases to be?):

Continue reading Journal retracts two chemistry papers for plagiarism

Editor: “Close to 10% of the papers we receive show some sign of academic misconduct”

elsevierThe latest issue of Elsevier’s Editors’ Update is part one of a two-part series on publishing ethics. It contains a bevy of articles on various issues that will be be familiar to Retraction Watch readers, from bias to research misconduct. (Not surprisingly, given the sheer number of journals they publish, Elsevier shows up regularly on Retraction Watch.)

In one of the pieces, Applied Surface Science editor in chief Henrik Rudolph pulls no punches: Continue reading Editor: “Close to 10% of the papers we receive show some sign of academic misconduct”

Author retracts materials paper for irreproducibility

tetrahedronA materials scientist in Turkey has retracted a paper in the journal Tetrahedron after realizing that there was more to the compounds he was studying than he thought.

The article, “Novel donor–acceptor type thiophene pyridine conjugates: synthesis and ion recognition features,” appeared in April and was written by Fatih Algi, of the Laboratory of Organic Materials at Canakkale Onsekiz Mart University.

Here’s the notice: Continue reading Author retracts materials paper for irreproducibility

Retraction for iffy data as authors of chicken enzyme paper lay an egg

IntjrnbiolmacroThe authors of an article in the International Journal of Biological Macromolecules have pulled the paper in what appears to be an authorship dispute sparked by premature submission.

The paper, “Renaturation and one step purification of the chicken GIIA secreted phospholipase A2 from inclusion bodies,” came from a group of researchers in Tunisia and Marseille, France, and was published online last May. It has yet to be cited, according to Thomson Scientific’s Web of Knowledge. As the abstract states:

Continue reading Retraction for iffy data as authors of chicken enzyme paper lay an egg

A Cancer Cell mega-correction for highly cited researcher who retracted paper earlier this year

cancer cell 9-13MIT’s Robert Weinberg, a leading cancer researcher who retracted a Cancer Cell paper earlier this year for “inappropriate presentation” of figures, has corrected a different paper in the same journal.

Here’s the correction for “Species- and Cell Type-Specific Requirements for Cellular Transformation:”

We were apprised recently of errors made in the assembly of Figures 2B, 3A, 4A, 4B, and 5G, resulting in the incorporation of incorrect representative images in these figures. These errors occurred during the electronic assembly and have no bearing on the conclusions of the study. The corrected figures are shown below. The authors apologize for any possible confusion this might have caused.

Here’s the original Figure 2 and caption, followed by the new version (read all the way to the end of the post for more details on how this came to light): Continue reading A Cancer Cell mega-correction for highly cited researcher who retracted paper earlier this year

Lancet retracts Jikei Heart Study of valsartan following investigation

logo_lancetThe Lancet has retracted a study of Novartis’ blood pressure drug valsartan (Diovan) that has been subject to an investigation following the retraction of a related study earlier this year.

Continue reading Lancet retracts Jikei Heart Study of valsartan following investigation

When two words colloid: “copied and manipulated” figures prompt retraction of nanoparticle paper

colloids and surfaces bThe journal Colloids and Surfaces B: Biointerfaces has retracted a 2011 paper by a group of researchers in India who misappropriated — and then manhandled — a pair of images from a previously published article by other scientists.

The paper, “Synthesis and characterization of chitosan and grape polyphenols stabilized palladium nanoparticles and their antibacterial activity,” was written by authors from various institutions in Tamil Nadu, and appeared online in December 2011 and in print the following April. It has been cited three times, according to Thomson Scientific’s Web of Knowledge.

Here’s the abstract: Continue reading When two words colloid: “copied and manipulated” figures prompt retraction of nanoparticle paper